|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.160 USD | +5.33% |
|
+3.45% | -14.07% |
| 05-15 | Fortress Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-21 | Journey Medical Corporation secures contract with third major GPO for Emrosi | RE |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Neutral |
| Resistance | 3.16 | 4.38 | 4.3 |
| Spread/Res. | -0.47% | -28.20% | -26.86% |
| Spread/Supp. | +22.37% | +41.67% | +73.76% |
| Support | 2.57 | 2.22 | 1.81 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- FBIO Stock
- Charts Fortress Biotech, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
